Key Events This Week
Feb 9: Stock opens at Rs.24.87, modest gain despite Sensex rally
Feb 10: Continued incremental gains on rising volumes
Feb 11: Profit-taking leads to 1.64% decline amid Sensex gains
Feb 12: Strong rebound with 3.42% surge on heavy volume
Feb 13: Quarterly results reveal strong turnaround but stock closes lower by 2.20%
Monday, 9 February 2026: Modest Start Amid Broad Market Rally
Mukka Proteins began the week at Rs.24.87, gaining 0.40% on volume of 26,668 shares. This was a cautious but positive start, though the Sensex outperformed with a 1.04% gain to 37,113.23 points. The stock’s limited upside relative to the benchmark suggested investors were awaiting fresh catalysts amid a broadly optimistic market mood.
Tuesday, 10 February 2026: Incremental Gains on Rising Volumes
The stock continued its gradual ascent, closing at Rs.24.99, up 0.48% on increased volume of 50,151 shares. The Sensex also advanced, albeit more modestly by 0.25% to 37,207.34. The steady buying interest indicated growing investor confidence ahead of the company’s quarterly results, with volumes nearly doubling from the previous day.
Wednesday, 11 February 2026: Profit-Taking Triggers 1.64% Decline
Profit-taking emerged midweek as Mukka Proteins slipped 1.64% to Rs.24.58 on lighter volume of 22,293 shares. This decline contrasted with the Sensex’s modest 0.13% gain to 37,256.72, reflecting selective selling pressure on the stock despite a broadly positive market. The dip was likely a short-term reaction ahead of the earnings announcement.
Thursday, 12 February 2026: Strong Rebound on Heavy Volume
In a sharp turnaround, Mukka Proteins surged 3.42% to Rs.25.42, its weekly high, on robust volume of 85,700 shares. This rally occurred despite the Sensex retreating 0.56% to 37,049.40, highlighting stock-specific strength. The surge was driven by anticipation of a strong quarterly performance, with investors positioning ahead of the results release.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Friday, 13 February 2026: Quarterly Results Reveal Strong Turnaround but Stock Retreats
Mukka Proteins reported a robust quarterly turnaround for the December 2025 quarter, with net sales reaching a record ₹653.50 crores and profit after tax doubling to ₹23.75 crores, a 101.1% increase over the previous four-quarter average. Operating profits also hit a recent high with PBDIT at ₹45.44 crores and PBT excluding other income at ₹29.69 crores, signalling renewed operational strength despite sector challenges.
However, the stock closed lower by 2.20% at Rs.24.86 on heavy volume of 78,560 shares, underperforming the Sensex which declined 1.40% to 36,532.48. The decline reflected investor caution due to rising interest expenses, which hit a quarterly high of ₹14.56 crores, potentially tempering margin expansion. The company’s financial trend score improved markedly from -8 to +15, and its Mojo Grade was upgraded to Hold, indicating cautious optimism.
Holding Mukka Proteins Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Weekly Price Performance: Mukka Proteins vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-09 | Rs.24.87 | +0.40% | 37,113.23 | +1.04% |
| 2026-02-10 | Rs.24.99 | +0.48% | 37,207.34 | +0.25% |
| 2026-02-11 | Rs.24.58 | -1.64% | 37,256.72 | +0.13% |
| 2026-02-12 | Rs.25.42 | +3.42% | 37,049.40 | -0.56% |
| 2026-02-13 | Rs.24.86 | -2.20% | 36,532.48 | -1.40% |
Key Takeaways
Positive Signals: Mukka Proteins demonstrated a strong quarterly turnaround with record net sales of ₹653.50 crores and a doubling of PAT to ₹23.75 crores, reflecting operational improvements and effective cost management. The company’s financial trend score improved significantly, and the Mojo Grade upgrade to Hold signals cautious analyst optimism. The stock outperformed the Sensex over the week, gaining 0.36% versus the index’s 0.54% decline, supported by strong volume on the rebound day.
Cautionary Factors: Despite margin expansion, rising interest expenses to ₹14.56 crores represent a financial leverage risk that could constrain future earnings growth. The stock’s 1-year return remains negative at -28.44%, lagging the Sensex’s 8.90% gain, indicating that the recent positive momentum is still in early stages of market recognition. The share price volatility during the week, including a 2.20% drop on results day, suggests investor caution amid sector headwinds.
Conclusion
Mukka Proteins Ltd’s performance this week was characterised by a modest overall gain that outpaced the broader market decline, driven primarily by a strong quarterly earnings turnaround. The company’s record sales and profit growth amid FMCG sector challenges highlight operational resilience. However, elevated interest costs and historical volatility temper the outlook, suggesting that while the turnaround is promising, it remains subject to risks. The Hold rating and moderate Mojo Score of 51.0 reflect a balanced view of potential and caution. Investors should monitor margin trends and debt levels closely as Mukka Proteins seeks to consolidate its recovery in a competitive environment.
Unlock special upgrade rates for a limited period. Start Saving Now →
